Paris Based Enterome News Today

Nestlé is providing EUR40m (US$40.7m) to Paris-based Enterome in a project targeting food allergies and inflammatory bowel disease (IBD).

With a €49M ($60M) Series A, the French firm eureKARE debuted this month with the goal of priming the translational pump in hot areas where European academics have already made a mark, particularly the microbiome.